Skip to content

Svenningsson lab

Translational Research on Neuropharmacology and Movement Disorders

  • Home
  • News
  • Research
    • Pre-Clinical
      • P11 and G protein-coupled receptor function & pharmacology
      • Proteinopathies
    • Clinical
      • Clinical trials and Biomarkers in Parkinsonism
      • Ataxia, spastic paraparesis, chorea and other movement disorders
      • The role of glycemic control in Parkinson’s disease
  • Publications
  • People
    • Core Pre-Clinical Group
    • Core Clinical Group
    • Join our team
    • Alumni
    • Lab Group photos
  • Funding
  • Outreach
  • För Patienter
  • Contact
Posted on 1 June 20217 July 2021 by Marcus Saarinen

Wallenberg Clinical Scholars prolongation grant

Per Svenningsson was granted an extended Wallenberg Clinical Scholars grant for another five years.

See announcement here

Info about the Wallenberg Foundations on KI webpage

CategoriesFunding TagsFunding, KAW, Parkinson's Disease, Per Svenningsson, Wallenberg Clinical Scholars

Post navigation

Previous PostPrevious Co-authorship in a Nature article
Next PostNext Article published in Biological Psychiatry and featured with commentary and issue cover.

Postal Address

Karolinska Institutet
NKS, Bioclinicum
Visionsgatan 4
J5:20 Neuro- Svenningsson
Solna, 171 64

Telephone

+46 851774614

Our Karolinska Institute webpage

https://ki.se/en/cns/per-svenningssons-research-group-0

 

Proudly powered by WordPress